Pancreatic injury and acute pancreatitis in COVID-19 patients
- PMID: 33569964
- DOI: 10.17235/reed.2021.7807/2021
Pancreatic injury and acute pancreatitis in COVID-19 patients
Abstract
Apart from pulmonary manifestations, there is an increased incidence of pancreatic involvement and acute pancreatitis (AP) reported in COVID-19 patients. In January 2021, a PubMed search using the terms "Acute Pancreatitis, COVID-19" yielded a result including 94 studies. Most of the studies refer to isolated cases or limited series, with the added difficulty that some authors have considered AP as elevated lipase and/or amylase levels without the diagnostic criteria for AP being met, as highlighted by Chivato et al. in relation to the case they report. Pancreatic involvement has been reported in 17 % of COVID-19 patients and AP in 1.8-2.0 % of these patients.
Comment in
-
Acute pancreatitis related to SARS-CoV-2 infection. Disclaimer.Rev Esp Enferm Dig. 2021 May;113(5):390. doi: 10.17235/reed.2021.7853/2021. Rev Esp Enferm Dig. 2021. PMID: 33569960
Comment on
-
Coronavirus disease 2019 and the pancreas.Pancreatology. 2020 Dec;20(8):1567-1575. doi: 10.1016/j.pan.2020.10.035. Epub 2020 Oct 12. Pancreatology. 2020. PMID: 33250089 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
